A citation-based method for searching scientific literature

Mei Shi, Rong Tang, Fansu Huang, Ting Zhong, Yan Chen, Xia Li, Zhiguang Zhou. Diabetes Metab Res Rev 2021
Times Cited: 3







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Hong Yi, Rui Peng, Lu-Yu Zhang, Yan Sun, Hui-Min Peng, Han-Deng Liu, Li-Juan Yu, Ai-Ling Li, Ya-Juan Zhang, Wen-Hao Jiang,[...]. Cell Death Dis 2017
126
33

Long noncoding RNA MEG3 suppresses podocyte injury in diabetic nephropathy by inactivating Wnt/β-catenin signaling.
Xiajing Che, Xin Deng, Kewei Xie, Qin Wang, Jiayi Yan, Xinghua Shao, Zhaohui Ni, Liang Ying. PeerJ 2019
7
33

Snail1: A Transcriptional Factor Controlled at Multiple Levels.
Josep Baulida, Víctor M Díaz, Antonio García de Herreros. J Clin Med 2019
17
33

Towards a molecular understanding of microRNA-mediated gene silencing.
Stefanie Jonas, Elisa Izaurralde. Nat Rev Genet 2015
948
33


lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury.
Jun Zhang, Tingting Jiang, Xiujie Liang, Shuangshuang Shu, Xiaohong Xiang, Wenying Zhang, Tingting Guo, Wei Xie, Weiqian Deng, Xun Tang. J Physiol Biochem 2019
13
33

CLDN6 promotes tumor progression through the YAP1-snail1 axis in gastric cancer.
Site Yu, Yeqian Zhang, Qing Li, Zizhen Zhang, Gang Zhao, Jia Xu. Cell Death Dis 2019
16
33


LncRNA Blnc1 expression and its effect on renal fibrosis in diabetic nephropathy.
Xianzhen Feng, Jin Zhao, Jingjing Ding, Xiaoyi Shen, Jun Zhou, Zhongqing Xu. Am J Transl Res 2019
20
33

High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.
Toshiyuki Imasawa, Emilie Obre, Nadège Bellance, Julie Lavie, Tomoko Imasawa, Claire Rigothier, Yahsou Delmas, Christian Combe, Didier Lacombe, Giovanni Benard,[...]. FASEB J 2017
37
33

Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.
Xue Li, Li Zeng, Chuanwu Cao, Chenhui Lu, Weishuai Lian, Jianhong Han, Xiaojun Zhang, Jing Zhang, Tao Tang, Maoquan Li. Exp Cell Res 2017
132
33

Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression.
Xiaoxu Ge, Bojin Xu, Wenwei Xu, Lili Xia, Zhongqin Xu, Lisha Shen, Wenfang Peng, Shan Huang. Aging (Albany NY) 2019
39
33

The ZSWIM8 ubiquitin ligase mediates target-directed microRNA degradation.
Charlie Y Shi, Elena R Kingston, Benjamin Kleaveland, Daniel H Lin, Michael W Stubna, David P Bartel. Science 2020
27
33

IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model.
Rong Dong, Jiali Yu, Funxun Yu, Song Yang, Qi Qian, Yan Zha. Am J Physiol Endocrinol Metab 2019
4
33

Long noncoding RNA Tug1 regulates mitochondrial bioenergetics in diabetic nephropathy.
Jianyin Long, Shawn S Badal, Zengchun Ye, Yin Wang, Bernard A Ayanga, Daniel L Galvan, Nathanael H Green, Benny H Chang, Paul A Overbeek, Farhad R Danesh. J Clin Invest 2016
195
33


Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease.
M Teresa Grande, Berta Sánchez-Laorden, Cristina López-Blau, Cristina A De Frutos, Agnès Boutet, Miguel Arévalo, R Grant Rowe, Stephen J Weiss, José M López-Novoa, M Angela Nieto. Nat Med 2015
395
33

MiR-325-3p inhibits renal inflammation and fibrosis by targeting CCL19 in diabetic nephropathy.
Jiping Sun, Jing Wang, Wanhong Lu, Liyi Xie, Jing Lv, Huixian Li, Shifeng Yang. Clin Exp Pharmacol Physiol 2020
11
33


LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis.
Yang Li, Lin-Lin Zheng, Deng-Gao Huang, Hui Cao, Yuan-Hui Gao, Zhong-Cheng Fan. Biomed Pharmacother 2020
16
33

MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-beta-induced collagen expression via inhibition of E-box repressors.
Mitsuo Kato, Jane Zhang, Mei Wang, Linda Lanting, Hang Yuan, John J Rossi, Rama Natarajan. Proc Natl Acad Sci U S A 2007
533
33

Oxidative Stress Markers in Chronic Kidney Disease with Emphasis on Diabetic Nephropathy.
Nina Vodošek Hojs, Sebastjan Bevc, Robert Ekart, Radovan Hojs. Antioxidants (Basel) 2020
11
33

Metazoan MicroRNAs.
David P Bartel. Cell 2018
33

Platforms for Investigating LncRNA Functions.
John Lalith Charles Richard, Pieter Johan Adam Eichhorn. SLAS Technol 2018
64
33

Dub3 inhibition suppresses breast cancer invasion and metastasis by promoting Snail1 degradation.
Yadi Wu, Yu Wang, Yiwei Lin, Yajuan Liu, Yifan Wang, Jianhang Jia, Puja Singh, Young-In Chi, Chi Wang, Chenfang Dong,[...]. Nat Commun 2017
69
33

High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism.
Paola Massucco, Luigi Mattiello, Isabella Russo, Monica Traversa, Gabriella Doronzo, Giovanni Anfossi, Mariella Trovati. Thromb Haemost 2005
18
33

Is aspirin effective in diabetic patients? Yes.
J A Colwell. J Thromb Haemost 2005
6
33

Thrombopoietin contributes to enhanced platelet activation in patients with unstable angina.
Enrico Lupia, Ornella Bosco, Serena Bergerone, Anna Erna Dondi, Alberto Goffi, Elena Oliaro, Marco Cordero, Lorenzo Del Sorbo, Giampaolo Trevi, Giuseppe Montrucchio. J Am Coll Cardiol 2006
36
33

Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin.
S Guthikonda, E I Lev, R Patel, T DeLao, A L Bergeron, J-F Dong, N S Kleiman. J Thromb Haemost 2007
180
33

Elevated thrombopoietin in plasma of burned patients without and with sepsis enhances platelet activation.
E Lupia, O Bosco, F Mariano, A E Dondi, A Goffi, T Spatola, A Cuccurullo, P Tizzani, G Brondino, M Stella,[...]. J Thromb Haemost 2009
29
33

Effects of recombinant human megakaryocyte growth and development factor on platelet activation.
G Montrucchio, M F Brizzi, G Calosso, S Marengo, L Pegoraro, G Camussi. Blood 1996
66
33

Decreased platelet membrane fluidity due to glycation or acetylation of membrane proteins.
P D Winocour, C Watala, D W Perry, R L Kinlough-Rathbone. Thromb Haemost 1992
75
33


Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
C C Folman, G E Linthorst, J van Mourik, G van Willigen, E de Jonge, M Levi, M de Haas, A E von dem Borne. Thromb Haemost 2000
56
33

Thrombopoietin primes human platelet aggregation induced by shear stress and by multiple agonists.
A Oda, Y Miyakawa, B J Druker, K Ozaki, K Yabusaki, Y Shirasawa, M Handa, T Kato, H Miyazaki, A Shimosaka,[...]. Blood 1996
106
33

Platelets and diabetes mellitus.
Francesca Santilli, Paola Simeone, Rossella Liani, Giovanni Davì. Prostaglandins Other Lipid Mediat 2015
55
33


The mean platelet volume in subjects with impaired fasting glucose.
Erkan Coban, F Bostan, M Ozdogan. Platelets 2006
85
33

Thrombopoietin as biomarker and mediator of cardiovascular damage in critical diseases.
Enrico Lupia, Alberto Goffi, Ornella Bosco, Giuseppe Montrucchio. Mediators Inflamm 2012
24
33

Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
L A Harker, U M Marzec, P Hunt, A B Kelly, A Tomer, E Cheung, S R Hanson, R B Stead. Blood 1996
124
33


Coagulation and fibrinolysis in diabetes.
S H Alzahrani, R A Ajjan. Diab Vasc Dis Res 2010
140
33

In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
Francesco Zaccardi, Alessandro Rizzi, Giovanna Petrucci, Flavia Ciaffardini, Luigi Tanese, Francesca Pagliaccia, Viviana Cavalca, Angela Ciminello, Aida Habib, Isabella Squellerio,[...]. Diabetes 2016
24
33

Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo").
David Vivas, Juan C García-Rubira, Esther Bernardo, Dominick J Angiolillo, Patricia Martín, Alfonso Calle-Pascual, Iván Núñez-Gil, Carlos Macaya, Antonio Fernández-Ortiz. Heart 2011
24
33

Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Sasidhar Guthikonda, Carlos L Alviar, Muthiah Vaduganathan, Mehmet Arikan, Armando Tellez, Timothy DeLao, Juan F Granada, Jing-Fei Dong, Neal S Kleiman, Eli I Lev. J Am Coll Cardiol 2008
240
33

Cardiovascular complications of type 1 diabetes: update on the renal link.
Trevor J Orchard, Tina Costacou. Acta Diabetol 2017
11
33


The Main Determinants of Diabetes Mellitus Vascular Complications: Endothelial Dysfunction and Platelet Hyperaggregation.
Albino Carrizzo, Carmine Izzo, Marco Oliveti, Antonia Alfano, Nicola Virtuoso, Mario Capunzo, Paola Di Pietro, Mariaconsiglia Calabrese, Eros De Simone, Sebastiano Sciarretta,[...]. Int J Mol Sci 2018
19
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.